Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06228079 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria revisedv5
  2. Site details revised at 7 of 7 sitesv4
  3. Eligibility criteria shortened, about 24 words
    • Site details revised at 7 of 7 sites
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Feb 1, 2024 to Jun 25, 2024
    • Site details revised at 7 of 7 sites
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Adjuvant Therapy Versus Endoscopic Surgery Alone in Early-stage Recurrent Nasopharyngeal Carcinoma: A Multicenter Randomized Controlled Trial
Trial Details
NCT Number NCT06228079
Lead Sponsor Eye & ENT Hospital of Fudan University
Collaborators: Shanghai Zhongshan Hospital, Shanghai 6th People's Hospital, Changhai Hospital, Fujian Medical University Union Hospital, People's Hospital of Guangxi Zhuang Autonomous Region, Shenzhen Second People's Hospital
Conditions
(from sponsor)		 Recurrent Nasopharyngeal Carcinoma
Related terms Nasopharyngeal Carcinoma
Enrollment 176 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov